GO:0004103 choline kinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004103 choline kinase activity is a molecular function that catalyzes the phosphorylation of choline to phosphocholine, the first committed step in phosphatidylcholine biosynthesis.
• Choline kinase enzymes are encoded by CHKA and CHKB in humans, and their activity is essential for membrane phospholipid synthesis and cell proliferation.
• Choline kinase activity is regulated by oncogenic signaling pathways, including Ras, Ral-GDS, and PI3K, linking it to cancer metabolism.
• Elevated choline kinase activity is a metabolic hallmark of many cancers and is being pursued as a therapeutic target with small-molecule inhibitors.
• In endothelial cells, metabolic stress activates CHKA, contributing to diabetes-associated microvascular dysfunction.
• Choline kinase is also a genetically validated drug target in Trypanosoma brucei, highlighting its broader biomedical relevance.
Description
Choline kinase activity (GO:0004103) is a molecular function that catalyzes the ATP-dependent phosphorylation of choline to produce phosphocholine and ADP. This reaction is the first committed and rate-limiting step in the Kennedy pathway for phosphatidylcholine biosynthesis, a major phospholipid in eukaryotic membranes. Because phosphatidylcholine is essential for membrane biogenesis and cell proliferation, choline kinase activity is tightly linked to growth control and has been extensively studied in cancer and metabolic disorders. The enzyme is encoded by two genes in humans, CHKA and CHKB, which form homo- and heterodimers with distinct catalytic and regulatory properties. Beyond its role in phospholipid metabolism, choline kinase activity influences signaling lipids and membrane dynamics, making it a focal point for understanding how metabolic enzymes contribute to disease. Researchers study choline kinase activity to dissect metabolic reprogramming in cancer, to develop inhibitors for therapeutic intervention, and to explore its role in normal physiology such as endothelial function and liver homeostasis.
choline kinase activity At A Glance
| GO ID | GO:0004103 |
|---|---|
| GO term | choline kinase activity |
| Ontology | molecular_function |
| Synonym | None listed in QuickGO |
| Major function | Catalyzes phosphorylation of choline to phosphocholine using ATP |
| EC number | 2.7.1.32 |
| Reaction | ATP + choline = ADP + phosphocholine |
| Pathway | Kennedy pathway for phosphatidylcholine biosynthesis |
| Human genes | CHKA, CHKB |
What Is GO:0004103?
In our own words, GO:0004103 choline kinase activity describes the enzymatic function of transferring a phosphate group from ATP to choline, yielding phosphocholine and ADP. This activity is the defining catalytic property of choline kinase enzymes and represents the entry point for choline into the phosphatidylcholine biosynthetic pathway. The term is classified as a molecular function in the Gene Ontology, although it is often discussed in the context of biological processes such as phospholipid metabolism and cell proliferation.
Why Is choline kinase activity Important in Cell Biology?
Choline kinase activity is important because it controls the flux of choline into phosphatidylcholine, a phospholipid required for membrane assembly and cell division. Dysregulated choline kinase activity is a metabolic hallmark of cancer, where it supports rapid proliferation and is associated with poor prognosis. Inhibitors of choline kinase have shown anticancer activity in preclinical models, validating the enzyme as a therapeutic target. Moreover, choline kinase activity is implicated in diabetes-associated microvascular dysfunction and in liver fibrosis, indicating broad physiological and pathological relevance beyond oncology.
• Provides the first committed step in phosphatidylcholine biosynthesis, essential for membrane biogenesis.
• Supports rapid cell proliferation in cancer by supplying phosphocholine for membrane lipids.
• Is regulated by oncogenic Ras and PI3K signaling, linking metabolism to growth control.
• Represents a therapeutic target with small-molecule inhibitors showing anticancer activity.
• Contributes to diabetes-associated microvascular dysfunction via CHKA activation in endothelial cells.
• Is a genetically validated drug target in Trypanosoma brucei, relevant to neglected tropical diseases.
• May influence liver fibrosis through hepatocyte-derived extracellular vesicles.
• Serves as a biomarker of choline metabolism in cancer imaging and diagnostics.
• Plays a role in normal endothelial function and metabolic stress responses.
• Offers a model system for studying enzyme kinetics and fragment-based drug discovery.
Molecular Mechanism of choline kinase activity
Substrate binding and catalysis
In simple terms: Choline kinase grabs choline and ATP, then sticks a phosphate onto choline.
Choline kinase binds its substrates choline and ATP in an ordered manner. The enzyme transfers the gamma-phosphate of ATP to the hydroxyl group of choline, producing phosphocholine and ADP. This reaction is magnesium-dependent and follows a sequential kinetic mechanism. The catalytic efficiency of choline kinase is influenced by the oligomeric state of the enzyme, with dimers being more active than monomers.
Isoforms and oligomerization
In simple terms: There are two main versions of the enzyme, and they can pair up to work better.
In humans, choline kinase exists as two isoforms, CHKA and CHKB, which share significant sequence homology but differ in tissue distribution and regulation. These isoforms can form homodimers and heterodimers, and the dimeric forms exhibit higher catalytic activity. CHKA is ubiquitously expressed and often upregulated in cancer, while CHKB is more restricted and has been linked to muscular dystrophy in rare cases.
Regulation by oncogenic signaling
In simple terms: Cancer genes can turn up the activity of choline kinase.
Choline kinase activity is stimulated by oncogenic Ras proteins through a mechanism involving Ral-GDS and PI3K. This regulation connects growth factor signaling to phospholipid metabolism, ensuring that proliferating cells have sufficient phosphatidylcholine for membrane expansion. Inhibitors of PI3K or Ral-GDS reduce choline kinase activity, confirming the pathway's role in enzyme activation.
Inhibition by small molecules
In simple terms: Drug-like molecules can block choline kinase to slow cancer growth.
Several small-molecule inhibitors of choline kinase have been developed, including non-symmetrical compounds that compete with choline or ATP. These inhibitors reduce phosphocholine production and exhibit antiproliferative effects in cancer cell lines. Fragment-based screening has also identified starting points for inhibitor development against Trypanosoma brucei choline kinase.
Role in metabolic stress and endothelial function
In simple terms: When cells are stressed, choline kinase can become overactive and cause problems in blood vessels.
In endothelial cells, metabolic stress such as high glucose activates CHKA, leading to increased phosphocholine and contributing to microvascular dysfunction in diabetes. This activation is part of a maladaptive response that impairs endothelial function and promotes vascular complications.
Key Genes Involved in GO:0004103 choline kinase activity
The following genes and proteins are directly associated with choline kinase activity, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CHKA | Catalytic subunit of choline kinase; phosphorylates choline | Upregulated in many cancers; target for inhibitors |
| CHKB | Catalytic subunit; forms heterodimers with CHKA | Mutations cause muscular dystrophy; less studied in cancer |
| HRAS | Oncogene that activates choline kinase via Ral-GDS and PI3K | Links growth signaling to phospholipid metabolism |
| RALGDS | Guanine nucleotide exchange factor mediating Ras-induced choline kinase activation | Potential target to modulate choline kinase in cancer |
| PIK3CA | PI3K catalytic subunit; contributes to choline kinase activation | Frequently mutated in cancer; affects choline metabolism |
| TbCK | Choline kinase in Trypanosoma brucei | Genetically validated drug target for sleeping sickness |
| MASP1 | Hepatocyte-derived protein in extracellular vesicles | Linked to liver fibrosis; may influence choline metabolism |
| PCYT1A | CTP:phosphocholine cytidylyltransferase, downstream of choline kinase | Regulates phosphatidylcholine synthesis |
| CEPT1 | Choline/ethanolamine phosphotransferase, final step of Kennedy pathway | Affects phosphocholine utilization |
| PLD1 | Phospholipase D, produces phosphatidic acid from phosphatidylcholine | Cross-talk with choline kinase pathway |
| SLC44A1 | Choline transporter-like protein 1 | Influences substrate availability for choline kinase |
| SLC44A2 | Choline transporter-like protein 2 | May affect choline uptake and kinase activity |
| CHPT1 | Choline phosphotransferase 1 | Downstream enzyme in phosphatidylcholine synthesis |
| LPIN1 | Lipin 1, phosphatidate phosphatase | Interconnects lipid metabolism with choline kinase pathway |
| XBP1 | Transcription factor in unfolded protein response | May regulate CHKA expression under stress |
| HIF1A | Hypoxia-inducible factor 1-alpha | Potential regulator of choline kinase in hypoxia |
How Is choline kinase activity Regulated?
Choline kinase activity is regulated at multiple levels. Acutely, it is activated by oncogenic signaling through Ras, Ral-GDS, and PI3K. Chronically, expression of CHKA is induced by growth factors and metabolic stress, such as high glucose in endothelial cells. The enzyme's oligomeric state also modulates activity, with dimerization increasing catalytic efficiency. Additionally, feedback mechanisms involving downstream metabolites like phosphatidylcholine may influence flux through the pathway. Inhibitors and genetic knockdown studies have confirmed that reducing choline kinase activity decreases phosphocholine levels and impairs proliferation.
choline kinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CHKA | Cancer (breast, lung, prostate) | Knockout or overexpression in cancer cell lines; xenograft models |
| CHKA | Diabetes-associated microvascular dysfunction | Endothelial cell-specific knockout in diabetic mice |
| CHKB | Muscular dystrophy (rare) | Knockout mice or patient-derived cells |
| TbCK | African sleeping sickness | Trypanosoma brucei culture with inhibitors |
| MASP1 | Liver fibrosis | Hepatocyte-specific knockout or overexpression in mice |
Cancer
Choline kinase activity is elevated in many human cancers, including breast, lung, prostate, and colorectal cancers, where it correlates with poor prognosis. The increased activity supports the high demand for phosphatidylcholine during rapid proliferation. Oncogenic Ras and PI3K pathways drive this upregulation, making choline kinase a downstream effector of major oncogenic signals. Small-molecule inhibitors of choline kinase have demonstrated anticancer activity in preclinical models, reducing phosphocholine levels and inhibiting tumor growth.
Diabetes-associated microvascular dysfunction
In diabetes, metabolic stress activates CHKA in endothelial cells, leading to increased phosphocholine and impaired endothelial function. This contributes to microvascular complications such as retinopathy and nephropathy. Targeting CHKA may offer a therapeutic strategy to preserve endothelial health in diabetes.
Liver fibrosis
Hepatocyte-derived extracellular vesicles enriched in MASP1 activate hepatic stellate cells and promote liver fibrosis. Although the direct link to choline kinase activity is not fully established, altered choline metabolism in hepatocytes may influence this process. Further research is needed to clarify the role of choline kinase in liver fibrosis.
Infectious disease
Trypanosoma brucei choline kinase is a genetically validated drug target for African sleeping sickness. Inhibitors of this enzyme could provide new treatments for the disease. Fragment-based screening has identified chemical starting points for development.
From choline kinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CHKA loss reduce tumor growth? | CHKA knockout cancer cell lines and xenografts |
| How does CHKA point mutation affect catalysis? | CRISPR knock-in of catalytic-dead CHKA in cell lines |
| Does CHKA overexpression drive metabolic reprogramming? | Doxycycline-inducible CHKA overexpression in cancer cells |
| What is the role of CHKA in endothelial function? | Endothelial-specific CHKA knockout mice |
| Can choline kinase inhibitors be optimized? | Enzyme assays with recombinant CHKA and fragment libraries |
| How does CHKA regulation by Ras occur? | Cells with Ras mutations and PI3K inhibitors |
How to Study the choline kinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiometric enzyme assay | Choline kinase catalytic activity | Inhibitor screening and kinetic studies |
| LC-MS metabolomics | Phosphocholine and related metabolites | Metabolic profiling of cells and tissues |
| Western blot | CHKA/CHKB protein levels | Expression analysis in disease models |
| qRT-PCR | CHKA/CHKB mRNA levels | Transcriptional regulation studies |
| CRISPR knockout screen | Genes affecting choline kinase inhibitor sensitivity | Target discovery |
| Fragment-based screening | Binding of small molecules to choline kinase | Drug discovery |
| Immunofluorescence | Subcellular localization of choline kinase | Cell biology studies |
| Xenograft tumor models | In vivo tumor growth | Preclinical evaluation of inhibitors |
Enzyme activity assays
Choline kinase activity is typically measured using radiometric or coupled enzyme assays that detect the conversion of choline to phosphocholine. These assays use recombinant enzyme or cell lysates and can be adapted for high-throughput screening of inhibitors.
Metabolomics and lipidomics
Mass spectrometry-based metabolomics quantifies phosphocholine and other choline metabolites in cells and tissues. This approach reveals flux through the Kennedy pathway and the impact of genetic or pharmacological perturbations.
Expression analysis
Quantitative PCR, western blotting, and RNA-seq are used to measure CHKA and CHKB expression levels in different conditions. These methods help link choline kinase activity to transcriptional regulation and disease states.
CRISPR screening
Genome-wide CRISPR knockout screens can identify genes that modulate sensitivity to choline kinase inhibitors or regulate choline metabolism. Such screens provide unbiased insights into pathways that interact with choline kinase activity.
How CRISPR Can Be Used to Study GO:0004103 choline kinase activity
Knockout
CRISPR-Cas9 knockout of CHKA or CHKB in cell lines abolishes choline kinase activity, leading to reduced phosphocholine and impaired proliferation. These models are used to validate the enzyme's role in cancer and to identify compensatory pathways.
Point Mutation
Knock-in of point mutations in the catalytic domain of CHKA can dissect residues essential for substrate binding and catalysis. Such models help distinguish catalytic activity from non-catalytic functions.
Knock-in
Tagged knock-in of CHKA with fluorescent or affinity tags enables live-cell imaging and proteomic analysis of the enzyme. This approach reveals dynamic localization and interaction partners.
Overexpression
CRISPR activation or lentiviral overexpression of CHKA increases choline kinase activity and phosphocholine levels, mimicking the metabolic state of cancer cells. These models are useful for studying metabolic reprogramming and drug resistance.
How EDITGENE Supports choline kinase activity Research
Researchers studying choline kinase activity-related genes often need to determine whether a candidate gene is causally involved in phospholipid metabolism, cancer proliferation, or metabolic stress responses. EDITGENE provides a comprehensive suite of CRISPR-based services to create precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for choline kinase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| CHKA Knockout HEK293 Cell Line | EDJ-KQ3777 | Human | 1119 | Details Get a Quote |
| CHKB Knockout HEK293 Cell Line | EDJ-KQ4272 | Human | 1120 | Details Get a Quote |
| CHKA Knockout A-549 Cell Line | EDJ-KQ25872 | Human | 1119 | Details Get a Quote |
| CHKA Knockout HCT 116 Cell Line | EDJ-KQ25873 | Human | 1119 | Details Get a Quote |
| CHKA Knockout HeLa Cell Line | EDJ-KQ25874 | Human | 1119 | Details Get a Quote |
| CHKB Knockout A-549 Cell Line | EDJ-KQ26753 | Human | 1120 | Details Get a Quote |
| CHKB Knockout HCT 116 Cell Line | EDJ-KQ26754 | Human | 1120 | Details Get a Quote |
| CHKB Knockout HeLa Cell Line | EDJ-KQ26755 | Human | 1120 | Details Get a Quote |
Displaying Records 1 To 8 Of 8 Records
Frequently Asked Questions About choline kinase activity
What is choline kinase activity?
Choline kinase activity (GO:0004103) is the enzymatic function that phosphorylates choline to phosphocholine using ATP, the first step in phosphatidylcholine synthesis.
What genes are involved in choline kinase activity?
The main human genes are CHKA and CHKB, which encode the two isoforms of choline kinase.
How is choline kinase activity regulated?
It is regulated by oncogenic signaling through Ras, Ral-GDS, and PI3K, as well as by metabolic stress and oligomerization.
Why is choline kinase activity important in cancer?
Elevated choline kinase activity supports rapid membrane synthesis in proliferating cancer cells and is associated with poor prognosis.
What diseases are linked to choline kinase activity?
Cancer, diabetes-associated microvascular dysfunction, and rare muscular dystrophy linked to CHKB mutations.
How can I measure choline kinase activity?
Enzyme assays using radiolabeled choline or coupled detection systems, often combined with metabolomics.
What are choline kinase inhibitors?
Small molecules that block choline kinase activity, such as non-symmetrical inhibitors, which show anticancer effects in preclinical models.
Is choline kinase a drug target for parasitic diseases?
Yes, Trypanosoma brucei choline kinase is a genetically validated target for African sleeping sickness.
How does choline kinase contribute to diabetes complications?
Metabolic stress activates CHKA in endothelial cells, leading to microvascular dysfunction.
What CRISPR models are available for choline kinase research?
Knockout, point mutation, knock-in, and overexpression models can be generated for CHKA and CHKB to study function and disease.
Conclusion
Choline kinase activity (GO:0004103) is a fundamental enzymatic function that links choline metabolism to membrane phospholipid synthesis and cell growth. Its dysregulation is implicated in cancer, diabetes-associated vascular complications, and infectious diseases, making it a compelling target for therapeutic intervention. Continued research using CRISPR-engineered models and advanced metabolomics will further elucidate its mechanistic roles and facilitate drug discovery. EDITGENE offers comprehensive services to support these investigations with precision and scale.
References
- 1. Schiaffino-Ortega S et al.. 2021. Anticancer and Structure Activity Relationship of Non-Symmetrical Choline Kinase Inhibitors.. Pharmaceutics 13(9) PMID: 34575436
- 2. Ren L et al.. 2025. Metabolic Stress-Induced Choline Kinase α (CHKA) Activation in Endothelial Subpopulation Contributes to Diabetes-Associated Microvascular Dysfunction.. Adv Sci (Weinh) 12(33):e17045 PMID: 40548950
- 3. García-Molina P et al.. 2022. Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines.. Pharmaceutics 14(2) PMID: 35214160
- 4. El-Shemy HA et al.. 2013. Coupled Enzyme Activity and Thermal Shift Screening of the Maybridge Rule of 3 Fragment Library Against Trypanosoma brucei Choline Kinase; A Genetically Validated Drug Target.. PMID: 28045479
- 5. Wu G et al.. 2010. Choline kinase and its function.. Biochem Cell Biol 88(4):559-64 PMID: 20651826
- 6. Ramírez de Molina A et al.. 2002. Regulation of choline kinase activity by Ras proteins involves Ral-GDS and PI3K.. Oncogene 21(6):937-46 PMID: 11840339
- 8. Liu X et al.. 2023. Hepatocyte-derived MASP1-enriched small extracellular vesicles activate HSCs to promote liver fibrosis.. Hepatology 77(4):1181-1197 PMID: 35849032
